Nucleic acid drugs—current status, issues, and expectations for exosomes

Y Yamada - Cancers, 2021 - mdpi.com
Simple Summary Nucleic acid drugs provide novel therapeutic modalities with
characteristics that differ from those of small molecules and antibodies. In this review, I focus …

Roles of TGF-β signaling pathway in tumor microenvirionment and cancer therapy

H Zhao, J Wei, J Sun - International Immunopharmacology, 2020 - Elsevier
Transforming growth factor β (TGF-β) signaling pathway has pleiotropic effects on cell
proliferation, differentiation, adhesion, senescence, and apoptosis. TGF-β can be widely …

Temozolomide for high grade glioma

MG Hart, R Garside, G Rogers… - Cochrane Database of …, 2013 - cochranelibrary.com
Background High grade glioma (HGG) is an aggressive form of brain cancer. Treatment of
HGG usually entails biopsy, or resection if safe, followed by radiotherapy. Temozolomide is …

Immune escape in glioblastoma multiforme and the adaptation of immunotherapies for treatment

JRD Pearson, S Cuzzubbo, S McArthur… - Frontiers in …, 2020 - frontiersin.org
Glioblastoma multiforme (GBM) is the most frequently occurring primary brain tumor and has
a very poor prognosis, with only around 5% of patients surviving for a period of 5 years or …

Immunosuppressive mechanisms of malignant gliomas: parallels at non-CNS sites

P Perng, M Lim - Frontiers in oncology, 2015 - frontiersin.org
The central nervous system (CNS) possesses powerful local and global immunosuppressive
capabilities that modulate unwanted inflammatory reactions in nervous tissue. These same …

TGF-beta signaling in cancer treatment

I Fabregat, J Fernando, J Mainez… - Current pharmaceutical …, 2014 - ingentaconnect.com
The transforming growth factor-beta (TGF-!) belongs to a superfamily of cytokines that act on
protein kinase receptors at the plasma membrane to induce a plethora of biological signals …

14-3-3ζ turns TGF-β's function from tumor suppressor to metastasis promoter in breast cancer by contextual changes of Smad partners from p53 to Gli2

J Xu, S Acharya, O Sahin, Q Zhang, Y Saito, J Yao… - Cancer cell, 2015 - cell.com
Transforming growth factor β (TGF-β) functions as a tumor suppressor in premalignant cells
but as a metastasis promoter in cancer cells. The dichotomous functions of TGF-β are …

RNA-targeted therapeutics in cancer clinical trials: Current status and future directions

P Barata, AK Sood, DS Hong - Cancer treatment reviews, 2016 - Elsevier
Recent advances in RNA delivery and target selection provide unprecedented opportunities
for cancer treatment, especially for cancers that are particularly hard to treat with existing …

TGF-β signaling in health, disease, and therapeutics

Z Deng, T Fan, C Xiao, H Tian, Y Zheng, C Li… - Signal transduction and …, 2024 - nature.com
Transforming growth factor (TGF)-β is a multifunctional cytokine expressed by almost every
tissue and cell type. The signal transduction of TGF-β can stimulate diverse cellular …

Transforming growth factor-β in tumour development

CB Trelford, L Dagnino… - Frontiers in Molecular …, 2022 - frontiersin.org
Transforming growth factor-β (TGFβ) is a ubiquitous cytokine essential for embryonic
development and postnatal tissue homeostasis. TGFβ signalling regulates several biological …